Business Context and Reporting Period
Company: American Shared Hospital Services (ASHS)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2006
Business Overview: ASHS provides Gamma Knife radiosurgery units to medical centers. As of March 31, 2006, the company operated 21 units across 16 states. Revenue models include fee-per-use, turn-key, and net revenue sharing arrangements.
Key Financial Metrics
| Metric | Q1 2006 | Q1 2005 |
|---|---|---|
| Medical Services Revenue | $5,045,000 | $4,449,000 |
| Gross Margin | $2,423,000 (48.0%) | $2,292,000 (51.5%) |
| Operating Income | $946,000 | $836,000 |
| Net Income | $436,000 | $395,000 |
| Earnings Per Share (Diluted) | $0.09 | $0.08 |
| Net Cash from Operating Activities | $2,233,000 | $2,465,000 |
| Cash and Cash Equivalents (End of Period) | $1,166,000 | $7,842,000 |
| Total Debt (Current + Long-term) | $19,436,000 | N/A |
| Total Capital Leases (Current + Long-term) | $5,526,000 | N/A |
Note: Total Debt and Capital Leases calculated from Balance Sheet line items for Q1 2006.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased by $596,000 (13.4%) driven by the addition of three new Gamma Knife units that commenced operation in 2005 and an 8% increase in procedures at existing sites.
- Procedure Volume: Total procedures rose to 669 in Q1 2006 from 575 in Q1 2005.
- Cost Increases: Total costs of revenue increased by $465,000. Depreciation and amortization rose by $170,000 due to new units. Other direct operating costs increased by $214,000 due to insurance, taxes, and turn-key site operations.
- Operating Expenses: Selling and administrative expenses decreased slightly by $7,000 due to reduced marketing costs and the absence of a User's Group meeting in Q1 2006.
- Interest Expense: Increased by $28,000 due to financing for new units and refinancing of a mature unit, partially offset by lower rates on newer loans.
- Stock-Based Compensation: The company adopted FASB Statement No. 123R in 2006, resulting in an $8,000 expense for stock options, whereas no such cost was recorded in 2005 under the previous accounting method.
Guidance, Outlook, and Risks
- Investment in New Technology: On April 10, 2006 (subsequent to period end), ASHS invested $2,000,000 in Still River Systems, Inc., a development-stage company creating proton beam radiation therapy (PBRT) devices. ASHS also purchased an option for $1,000,000 to acquire two Clinatron-250 systems, with anticipated delivery in 2008. These systems are not yet FDA approved.
- Liquidity: The company maintains a $6,000,000 line of credit (undrawn as of March 31, 2006). Management believes cash flow from operations is adequate to meet scheduled debt obligations of approximately $6.8 million and capital lease payments of $1.4 million over the next 12 months.
- Dividends: A quarterly dividend of $0.0475 per share was declared on February 23, 2006, payable April 17, 2006.
- Risks: Forward-looking statements highlight risks associated with the Gamma Knife business, the development of IMRT and "The Operating Room for the 21st Century" programs, and the investment in Still River Systems without a proven product.
Investor Verification Checklist
- Debt Service Coverage: Verify the company's ability to service approximately $8.2 million in scheduled debt and lease payments over the next 12 months given the current cash balance of $1.2 million.
- Still River Investment: Assess the risk profile of the $3 million total commitment (investment + option) to Still River Systems, noting the lack of FDA approval for the PBRT technology.
- Revenue Mix: Monitor the shift in revenue mix between fee-per-use, turn-key, and net revenue sharing contracts, as turn-key arrangements expose the company to higher operating cost risks.
- Unit Utilization: Track procedure volume growth at the three new units added in 2005 to ensure they meet revenue projections.
- Accounting Changes: Review the impact of the new FASB 123R stock-based compensation standard on future earnings, though the initial impact was minimal ($8,000).